[Paradigm Medical Industries, Inc. Letterhead]




                                                    June 30, 2005


VIA FACSIMILE
-------------


Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W., Mail Stop 0306
Judiciary Plaza
Washington, D.C. 20549

Attn:    Thomas A. Jones, Esq.
         Senior Attorney

         Re:   Paradigm Medical Industries, Inc.
               Application for Withdrawal of Registration Statement on Form SB-2
               Commission File No. 333-106842

Ladies and Gentlemen:

         Paradigm  Medical  Industries,   Inc.,  a  Delaware   corporation  (the
"Registrant"),  hereby requests pursuant to Rule 477(a) of the Securities Act of
1933, as amended, that the Securities and Exchange Commission (the "Commission")
consent  to  the  withdrawal  of the  Registrant's  Registration  Statement  No.
333-106842,  on Form SB-2,  together with any exhibits filed thereto,  which was
previously filed with the Commission on February 3, 2005 and declared  effective
on February 10, 2005.

         The Registration Statement was filed (i) to register for sale shares of
Registrant's common stock and (ii) to register for resale shares of Registrant's
common stock for certain  shareholders,  optionholders  and  warrantholders.  In
order to reflect and disclose  material  changes in Company's  operations  since
February  3,  2005,  Registrant  filed  Post-Effective  Amendment  No.  1 to the
Registration Statement on Form SB-2 on June 29, 2005.

         Because  the  Registration  Statement  filed on  February 3, 2005 is no
longer  current,  and has been  superceded  by  Post-Effective  Amendment No. 1,
Registrant  requests for the withdrawal of the  Registration  Statement filed on
February 3, 2005.

         Please  direct any questions or comments  regarding  this filing to the
undersigned at (801) 977-8970 or Randall A. Mackey, Esq. at (801) 575-5000.

                                    PARADIGM MEDICAL INDUSTRIES, INC.



                                    By: /s/ John Y. Yoon      
                                       ------------------
                                       John Y. Yoon
                                       President and Chief Executive Officer